The use of nonspecific HDACis, such as panobinostat [212] as well as low doses of trichostatin A [218], was reported to increase the expression of PD-L1 and PD-L2 on the cell surface of tumor cells in murine models of melanoma and breast cancer. Here, PDCD1LG2 is linked to neoplasm.